Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationAccumulated Depreciation & AmortizationCost of RevenueEBIATGross ProfitLeasesLong-Term Debt IssuancesMachine, Furnitures, Fixtures & OtherNon-Current ReceivablesOther Gross PP&E AdjustmentsOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Property, Plant & Equipment (Gross)Receivables - NetShares IssuedShares OutstandingShares OutstandingShares RepurchasedShort-Term Debt repayments
Ratios

Bio-Techne (TECH) Leases (2019 - 2026)

Bio-Techne has reported Leases over the past 7 years, most recently at $68.2 million for Q4 2025.

  • For Q4 2025, Leases fell 20.07% year-over-year to $68.2 million; the TTM value through Dec 2025 reached $68.2 million, down 20.07%, while the annual FY2025 figure was $73.4 million, 19.59% down from the prior year.
  • Leases for Q4 2025 was $68.2 million at Bio-Techne, down from $70.7 million in the prior quarter.
  • Over five years, Leases peaked at $102.3 million in Q3 2023 and troughed at $63.4 million in Q1 2022.
  • A 5-year average of $81.1 million and a median of $78.8 million in 2021 define the central range for Leases.
  • Biggest five-year swings in Leases: surged 54.41% in 2023 and later dropped 20.73% in 2025.
  • Year by year, Leases stood at $64.3 million in 2021, then surged by 30.55% to $83.9 million in 2022, then rose by 20.17% to $100.9 million in 2023, then dropped by 15.35% to $85.4 million in 2024, then decreased by 20.07% to $68.2 million in 2025.
  • Business Quant data shows Leases for TECH at $68.2 million in Q4 2025, $70.7 million in Q3 2025, and $73.4 million in Q2 2025.